Dr. Guohai Shi 施国海
Chief Physician, Associate Professor
Department of Urology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, surgery, and minimally invasive treatment of urinary tract tumors; systemic therapy for advanced tumors including molecular targeted therapy; diagnosis and treatment of tuberous sclerosis.
Dr. Shi holds a medical doctorate and has over 10 years of experience in urology. Training includes a clinical bachelor’s from Harbin Medical University (2001), a PhD from Shanghai Jiao Tong University School of Medicine (2007), national GCP training (2007), Sino-European urology training (2010), and a visit to Vienna General Hospital (2011). Dr. Shi is an international member of the American Urological Association (AUA) and a member of the China Anti-Cancer Association.
Professional roles
- Reviewer, Chemistry Medical Research
- Reviewer, Journal of Cancer and Clinical Oncology
- Judge, Pudong Science and Technology Development Fund
- Chief Examiner, Shanghai Standardized Residency Training
Name order: in Chinese the family name comes first (Shi Guohai). Papers usually list the name as Guohai Shi or Shi G.
Selected publications
134 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Cell Dev Biol, 2023 (senior author): Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy. PubMed 37427373
- World J Urol, 2019 (senior author): Incorporating non-biological factors into the TNM staging system for better prognostication and decision-making in testicular cancer. PubMed 30554272
- J Med Econ, 2018 (first author): Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China. PubMed 30134758
- Sci Rep, 2015 (senior author): Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer. PubMed 25563505
- Asian J Androl, 2014 (senior author): Genitourinary small-cell carcinoma: 11-year treatment experience. PubMed 24713837
- Onco Targets Ther, 2013 (senior author): B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma. PubMed 24265557
- Urol Int, 2012 (senior author): Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytology. PubMed 22104957
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion